Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma.

Cescon M, Ravaioli M, Grazi GL, Ercolani G, Cucchetti A, Bertuzzo V, Vetrone G, Del Gaudio M, Vivarelli M, D'Errico-Grigioni A, Dazzi A, Di Gioia P, Lauro A, Pinna AD.

J Transplant. 2010;2010. pii: 904152. doi: 10.1155/2010/904152. Epub 2010 Aug 25.

2.

AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma.

Yaprak O, Akyildiz M, Dayangac M, Demirbas BT, Guler N, Dogusoy GB, Yuzer Y, Tokat Y.

Hepatobiliary Pancreat Dis Int. 2012 Jun;11(3):256-61.

PMID:
22672818
3.

Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria.

Hameed B, Mehta N, Sapisochin G, Roberts JP, Yao FY.

Liver Transpl. 2014 Aug;20(8):945-51. doi: 10.1002/lt.23904. Epub 2014 Jul 12.

4.

Pretransplantation α-fetoprotein slope and milan criteria: strong predictors of hepatocellular carcinoma recurrence after transplantation.

Dumitra TC, Dumitra S, Metrakos PP, Barkun JS, Chaudhury P, Deschênes M, Paraskevas S, Hassanain M, Tchervenkov JI.

Transplantation. 2013 Jan 15;95(1):228-33. doi: 10.1097/TP.0b013e31827743d7. Erratum in: Transplantation. 2013 Feb 27;95(4):e23.

PMID:
23222895
5.

Histological differentiation predicts post-liver transplantation survival time.

Li WX, Li Z, Gao PJ, Gao J, Zhu JY.

Clin Res Hepatol Gastroenterol. 2014 Apr;38(2):201-8. doi: 10.1016/j.clinre.2013.11.002. Epub 2013 Dec 30.

PMID:
24388339
6.

Hepatocellular carcinoma and liver transplantation: a 12-year experience.

Varona MA, Del Pino JM, Barrera M, Arranz J, Hernández BM, Perez HF, Padilla J, Fuentes JS, Aguirre A, Mendez S, Sanz P, Gianchandani R, Perera A, Soriano A.

Transplant Proc. 2009 Apr;41(3):1005-8. doi: 10.1016/j.transproceed.2009.02.029.

PMID:
19376411
7.

Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA.

Duffy JP, Vardanian A, Benjamin E, Watson M, Farmer DG, Ghobrial RM, Lipshutz G, Yersiz H, Lu DS, Lassman C, Tong MJ, Hiatt JR, Busuttil RW.

Ann Surg. 2007 Sep;246(3):502-9; discussion 509-11.

8.

Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.

Shimoda M, Ghobrial RM, Carmody IC, Anselmo DM, Farmer DG, Yersiz H, Chen P, Dawson S, Durazo F, Han S, Goldstein LI, Saab S, Hiatt J, Busuttil RW.

Liver Transpl. 2004 Dec;10(12):1478-86.

9.

A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.

Agopian VG, Harlander-Locke M, Zarrinpar A, Kaldas FM, Farmer DG, Yersiz H, Finn RS, Tong M, Hiatt JR, Busuttil RW.

J Am Coll Surg. 2015 Apr;220(4):416-27. doi: 10.1016/j.jamcollsurg.2014.12.025. Epub 2014 Dec 27.

PMID:
25690672
10.

Hepatocellular carcinoma recurrence among liver transplant recipients within the Milan criteria.

Felga G, Evangelista AS, Salvalaggio PR, Curvelo LA, Della Guardia B, Almeida MD, Afonso RC, Ferraz-Neto BH.

Transplant Proc. 2012 Oct;44(8):2459-61. doi: 10.1016/j.transproceed.2012.07.004.

PMID:
23026620
11.

Salvage liver transplantation for patients with recurrent hepatocellular carcinoma after curative resection.

Wu L, Hu A, Tam N, Zhang J, Lin M, Guo Z, He X.

PLoS One. 2012;7(7):e41820. doi: 10.1371/journal.pone.0041820. Epub 2012 Jul 26.

12.

Prognostic impact of des-γ-carboxyl prothrombin in living-donor liver transplantation for recurrent hepatocellular carcinoma.

Harimoto N, Yoshida Y, Kurihara T, Takeishi K, Itoh S, Harada N, Tsujita E, Yamashita YI, Uchiyama H, Soejima Y, Ikegami T, Yoshizumi T, Kawanaka H, Ikeda T, Shirabe K, Saeki H, Oki E, Kimura Y, Maehara Y.

Transplant Proc. 2015 Apr;47(3):703-4. doi: 10.1016/j.transproceed.2014.09.178. Epub 2015 Mar 27.

PMID:
25819732
13.

α-Fetoprotein is a potential survival predictor in hepatocellular carcinoma patients with hepatitis B selected for liver transplantation.

Zhang Q, Shang L, Zang Y, Chen X, Zhang L, Wang Y, Wang L, Liu Y, Mao S, Shen Z.

Eur J Gastroenterol Hepatol. 2014 May;26(5):544-52. doi: 10.1097/MEG.0000000000000029.

PMID:
24614696
14.
15.

Predicting survival after liver transplantation using up-to-seven criteria in patients with hepatocellular carcinoma.

de Ataide EC, Garcia M, Mattosinho TJ, Almeida JR, Escanhoela CA, Boin IF.

Transplant Proc. 2012 Oct;44(8):2438-40. doi: 10.1016/j.transproceed.2012.07.006.

PMID:
23026614
16.

Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria.

Duvoux C, Roudot-Thoraval F, Decaens T, Pessione F, Badran H, Piardi T, Francoz C, Compagnon P, Vanlemmens C, Dumortier J, Dharancy S, Gugenheim J, Bernard PH, Adam R, Radenne S, Muscari F, Conti F, Hardwigsen J, Pageaux GP, Chazouillères O, Salame E, Hilleret MN, Lebray P, Abergel A, Debette-Gratien M, Kluger MD, Mallat A, Azoulay D, Cherqui D; Liver Transplantation French Study Group.

Gastroenterology. 2012 Oct;143(4):986-94.e3; quiz e14-5. doi: 10.1053/j.gastro.2012.05.052. Epub 2012 Jun 29.

PMID:
22750200
17.

Serum levels of preoperative α-fetoprotein and CA19-9 predict survival of hepatic carcinoma patients after liver transplantation.

Wan P, Zhang J, Long X, Li Q, Xu N, Zhang M, Chen X, Han L, Xia Q.

Eur J Gastroenterol Hepatol. 2014 May;26(5):553-61. doi: 10.1097/MEG.0000000000000070.

18.

Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.

Choi HJ, Kim DG, Na GH, Han JH, Hong TH, You YK.

World J Gastroenterol. 2013 Aug 7;19(29):4737-44. doi: 10.3748/wjg.v19.i29.4737.

19.

Prognostic factors for hepatocellular carcinoma recurrence: experience with 83 liver transplantation patients.

Ataide EC, Boin IF, Almeida JR, Sevá-Pereira T, Stucchi RS, Cardoso AR, Caruy CA, Escanhoela CA.

Transplant Proc. 2011 May;43(4):1362-4. doi: 10.1016/j.transproceed.2011.02.032.

20.

Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.

Bhattacharjya S, Bhattacharjya T, Quaglia A, Dhillon AP, Burroughs AK, Patch DW, Tibballs JM, Watkinson AF, Rolles K, Davidson BR.

Dig Surg. 2004;21(2):152-9; discussion 159-60. Epub 2004 May 27.

PMID:
15166485

Supplemental Content

Support Center